ClinicalTrials.gov
public full text
Public Domain
Evaluation of Weekly Tafenoquine
This study is a phase 2b, placebo controlled, randomized, blinded study of the efficacy of WR 238605, a new primaquine analog, compared to placebo as chemosuppression of P. falciparum malaria in Nyanza Province, western Kenya.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Post-discharge Malaria Chemoprevention Implementation Trial in Benin#1282155
- ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan#982430
- Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC#1350098
- Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial#993423
- A Phase I trial of non-invasive ventilation and seizure prophylaxis with levetiracetam in children with cerebral malaria trial (NOVICE-M Trial) [version 1; peer review: 2 approved]#355722
Record · ID 1364461
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive